Research Solutions Reports Third Quarter Fiscal Year 2026 Results
Rhea-AI Summary
Research Solutions (NASDAQ: RSSS) reported fiscal Q3 2026 results for the quarter ended March 31, 2026.
- Total revenue $12.1M, down 4.3% year-over-year
- ARR up 8.5% to $22.1M
- Net income $860K, or $0.03 per diluted share
- Adjusted EBITDA $1.6M, up 14%; TTM Adjusted EBITDA $6.0M (12.3% margin)
- Platform revenue $5.2M, up 6.6% and 43% of total revenue
- Transaction revenue $7.0M, down 11.0%
- Gross margin 51.7%, up 220 bps; gross profit $6.3M
- Operating cash flow $1.0M in Q3; $5.7M TTM
AI-generated analysis. Not financial advice.
Positive
- ARR increased 8.5% year-over-year to $22.1 million
- Net income rose to $860,000, or $0.03 per diluted share
- Adjusted EBITDA grew 14.1% year-over-year to $1.6 million
- TTM Adjusted EBITDA reached $6.0 million with a 12.3% margin
- Platform revenue grew 6.6% to $5.16 million and 43% of revenue
- Total gross margin expanded 220 basis points to 51.7%
- Total operating expenses declined 8.6% to $5.2 million
- Income from operations increased 87.6% to $1.0 million
Negative
- Total revenue declined 4.3% year-over-year to $12.1 million
- Transaction revenue fell 11.0% to $7.0 million
- Transaction customer count decreased 2.5% to 1,346
- B2C ARR declined 7.5% year-over-year to $6.36 million
- Quarterly operating cash flow decreased to $1.0 million from $2.9 million
- Nine-month sales and marketing expense increased 16.5% to $4.8 million
Key Figures
Market Reality Check
Peers on Argus
RSSS fell 4.56% while key peers showed mixed moves: IDN -26.08%, LPSN -2.71%, PSQH -11.07%, offset by gains in ILLR +9.27% and RDZN +5.62%. Only one peer appeared in the momentum scanner, suggesting stock-specific trading around earnings.
Previous Earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 12 | Q2 2026 earnings | Positive | -0.4% | Reported ARR growth to $21.8M and margin expansion with higher EBITDA. |
| Nov 13 | Q1 2026 earnings | Positive | +2.9% | Showed ARR up 21% to $21.3M and strong platform revenue growth. |
| Sep 18 | FY2025 results | Positive | -6.9% | Reported 36% platform growth, record ARR $20.9M and higher EBITDA. |
| Aug 19 | Prelim FY2025 results | Positive | -1.1% | Announced Q4 ARR of $20.9M and revenue growth with higher margins. |
| May 08 | Q3 2025 earnings | Positive | +9.6% | Delivered revenue growth, 23% ARR increase, and record EBITDA and cash flow. |
Earnings releases have generally highlighted ARR and margin growth, but price reactions have been mixed, with slightly more divergences than alignments.
Over the past year, RSSS earnings reports have emphasized SaaS transition and ARR growth. Q3 FY2025 delivered $12.7M revenue and $1.4M Adjusted EBITDA with ARR at $20.4M. FY2025 results showed record ARR of $20.9M and Adjusted EBITDA of $5.3M. Q1 and Q2 FY2026 continued this theme with ARR around $21.3–21.8M, expanding gross margins above 50%, and consistent profitability. The current Q3 FY2026 report, with ARR of $22.1M and higher net income, extends that trend despite modest revenue pressure.
Historical Comparison
Past earnings headlines for RSSS led to an average move of about 0.84%. Today’s -4.56% reaction to Q3 FY2026 results is larger in magnitude than typical same-tag events.
Earnings releases over the last five quarters show a progression from FY2025 record ARR of $20.9M to FY2026 quarters with ARR around $21–22M, expanding gross margins above 50%, and consistent profitability as platform revenue becomes a larger share of total.
Market Pulse Summary
This announcement highlights steady progress in recurring revenue and profitability. Q3 FY2026 ARR reached $22.1M, net income rose to $860,000, and Adjusted EBITDA was $1.6M with a 51.7% gross margin, even as total revenue eased to $12.1M on softer transaction volumes. Historically, earnings updates have focused on platform mix, ARR growth, and margin expansion. Investors may watch future quarters for transaction trends, deployment growth, and sustained cash generation.
Key Terms
annual recurring revenue financial
adjusted ebitda financial
basis points financial
gross margin financial
cash flow from operations financial
stock-based compensation financial
foreign currency translation financial
non-gaap financial
AI-generated analysis. Not financial advice.
Reports
Fiscal Third Quarter 2026 Summary (compared to prior-year quarter)
- Total revenue of
, compared to$12.1 million in the prior-year period.$12.7 million - Annual Recurring Revenue ("ARR") up
8.5% to$22.1 million , which includes approximately of B2B recurring revenue and$15.7 million of B2C recurring revenue.$6.4 million - Net income of
increased$860,000 297% , or per diluted share, compared to$0.03 or$216,000 per diluted share.$0.01 - Adjusted EBITDA increased
14% to . On a trailing twelve-month ("TTM") basis, the Company has now generated Adjusted EBITDA of$1.6 million $6.0 million , which represents a12.3% margin. - Platform revenue increased
6.6% to . Platform revenue accounted for$5.2 million 43% of total revenue as compared to38% in the prior-year quarter. - Fifteen net new deployments in the quarter and
10% deployment growth over past 12 months. - Cash flow from operations was
, compared to$1.0 million in the prior-year period, reflecting timing of billings and changes in working capital. On a trailing twelve-month basis, the Company has generated$2.9 million in cash flow from operations.$5.7 million - Total gross margin improved 220 basis points to
51.7% on gross profit of .$6.3 million
"We introduced a pair of new AI-based products in recent months, giving Article Galaxy and Scite users the ability to search, review and acquire scientific literature within their existing AI tools. Simplifying the process is critical in an ever-changing research environment, and these tools help us remain an integral partner with researchers. We remain focused on executing over the long term to drive value for our shareholders." said Roy W. Olivier, President and CEO of Research Solutions. "Our third quarter results reflect the improving profitability and growth prospects of our business, even within a softer operating environment. The continued focus across our Platform business is expanding consolidated gross margin and our strategic investment in sales and marketing is helping drive upsells for existing customers and signing larger deals with new logos."
Fiscal Third Quarter 2026 Results
Total revenue was
Platform subscription revenue for the quarter was
Transaction revenue was
Total gross margin improved 220 basis points from the prior-year quarter to
Total operating expenses were
Net income in the third quarter was
Conference Call
Management will host the conference call, followed by a question-and-answer period.
Date: Thursday, May 14, 2026
Time: 5:00 p.m. ET (2:00 p.m. PT)
Dial-in number: 1-203-518-9708
Conference ID: RESEARCH
The conference call will be broadcast live and available for replay until June 14, 2026 by dialing 1-412-317-6671 and using the replay ID 11160801, and via the investor relations section of the Company's website at http://researchsolutions.investorroom.com/.
Fiscal Third Quarter Financial and Operational Summary Tables vs. Prior-Year Quarter
Quarter Ended March 31, | Nine Months Ended March 31, | |||||||||
2026 | 2025 | Change | % Change | 2026 | 2025 | Change | % Change | |||
Revenue: | ||||||||||
Platforms | $ 5,160,565 | $ 4,839,929 | $ 320,636 | 6.6 % | $ 15,506,250 | $ 13,770,831 | $ 1,735,419 | 12.6 % | ||
Transactions | 6,960,996 | 7,821,434 | (860,438) | -11.0 % | 20,720,147 | 22,849,233 | (2,129,086) | -9.3 % | ||
Total Revenue | 12,121,561 | 12,661,363 | (539,802) | -4.3 % | 36,226,397 | 36,620,064 | (393,667) | -1.1 % | ||
Gross Profit: | ||||||||||
Platforms | 4,456,896 | 4,229,623 | 227,273 | 5.4 % | 13,569,545 | 11,993,516 | 1,576,029 | 13.1 % | ||
Transactions | 1,808,636 | 2,037,457 | (228,821) | -11.2 % | 5,098,235 | 5,860,533 | (762,298) | -13.0 % | ||
Total Gross Profit | 6,265,532 | 6,267,080 | (1,548) | 0.0 % | 18,667,780 | 17,854,049 | 813,731 | 4.6 % | ||
Gross profit as a % of revenue: | ||||||||||
Platforms | 86.4 % | 87.4 % | -1.0 % | 87.5 % | 87.1 % | 0.4 % | ||||
Transactions | 26.0 % | 26.0 % | -0.1 % | 24.6 % | 25.6 % | -1.0 % | ||||
Total Gross Profit | 51.7 % | 49.5 % | 2.2 % | 51.5 % | 48.8 % | 2.8 % | ||||
Operating Expenses: | ||||||||||
Sales and marketing | 1,508,897 | 1,607,678 | (98,781) | -6.1 % | 4,824,319 | 4,141,172 | 683,147 | 16.5 % | ||
Technology and product development | 1,513,074 | 1,394,936 | 118,138 | 8.5 % | 4,525,646 | 4,274,543 | 251,103 | 5.9 % | ||
General and administrative | 1,625,042 | 1,845,412 | (220,370) | -11.9 % | 4,920,996 | 5,783,789 | (862,794) | -14.9 % | ||
Depreciation and amortization | 312,402 | 312,013 | 389 | 0.1 % | 944,893 | 930,341 | 14,552 | 1.6 % | ||
Stock-based compensation | 248,608 | 594,639 | (346,031) | -58.2 % | 674,539 | 1,546,950 | (872,411) | -56.4 % | ||
Foreign currency translation loss (gain) | 12,529 | (44,519) | 57,048 | -128.1 % | 31,385 | (119,205) | 150,590 | 126.3 % | ||
Total Operating Expenses | 5,220,552 | 5,710,159 | (489,607) | -8.6 % | 15,921,778 | 16,557,590 | (635,813) | -3.8 % | ||
Income from operations | 1,044,980 | 556,921 | 488,059 | 87.6 % | 2,746,002 | 1,296,459 | 1,449,544 | 111.8 % | ||
Other Income (Expenses): | ||||||||||
Other expenses | (162,607) | (327,042) | 164,435 | 50.3 % | (537,232) | (2,316,404) | 1,779,172 | 76.8 % | ||
Provision for income taxes | (22,168) | (13,410) | (8,758) | -65.3 % | (52,258) | (74,816) | 22,558 | 30.2 % | ||
Total Other Expenses: | (184,775) | (340,452) | 155,677 | 45.7 % | (589,490) | (2,391,220) | 1,801,730 | 75.3 % | ||
Net income (loss) | $ 860,205 | $ 216,469 | 643,736 | 297.4 % | $ 2,156,512 | $ (1,094,761) | 3,251,274 | 297.0 % | ||
Adjusted EBITDA | $ 1,618,519 | $ 1,419,054 | $ 199,465 | 14.1 % | $ 4,396,819 | $ 3,654,545 | $ 742,274 | 20.3 % | ||
Quarter Ended March 31, | Nine Months Ended March 31, | |||||||||
2026 | 2025 | Change | % Change | 2026 | 2025 | Change | % Change | |||
Platforms: | ||||||||||
B2B ARR (Annual recurring revenue): | ||||||||||
Beginning of Period | $ 15,318,954 | $ 12,738,256 | $ 2,580,697 | 20.3 % | $ 14,197,598 | $ 12,060,201 | $ 2,137,397 | 17.7 % | ||
Incremental ARR | 397,970 | 735,818 | (337,848) | -45.9 % | 1,519,326 | 1,413,873 | 105,453 | 7.5 % | ||
End of Period | $ 15,716,923 | $ 13,474,074 | $ 2,242,849 | 16.6 % | $ 15,716,923 | $ 13,474,074 | $ 2,242,849 | 16.6 % | ||
Deployments: | ||||||||||
Beginning of Period | 1,232 | 1,090 | 142 | 13.0 % | 1,171 | 1,021 | 150 | 14.7 % | ||
Incremental Deployments | 15 | 43 | (28) | -65.1 % | 76 | 112 | (36) | -32.1 % | ||
End of Period | 1,247 | 1,133 | 114 | 10.1 % | 1,247 | 1,133 | 114 | 10.1 % | ||
ASP (Average sales price): | ||||||||||
Beginning of Period | $ 12,434 | $ 11,686 | $ 748 | 6.4 % | $ 12,124 | $ 11,812 | $ 312 | 2.6 % | ||
End of Period | $ 12,604 | $ 11,892 | $ 711 | 6.0 % | $ 12,604 | $ 11,892 | $ 711 | 6.0 % | ||
B2C ARR (Annual recurring revenue): | ||||||||||
Beginning of Period | $ 6,441,416 | $ 6,371,381 | $ 70,035 | 1.1 % | $ 6,721,356 | $ 5,363,129 | $ 1,358,227 | 25.3 % | ||
Incremental ARR | (80,748) | 506,545 | (587,293) | NM | (360,688) | 1,514,797 | (1,875,485) | -123.8 % | ||
End of Period | $ 6,360,668 | $ 6,877,926 | $ (517,258) | -7.5 % | $ 6,360,668 | $ 6,877,926 | $ (517,258) | -7.5 % | ||
Total ARR (Annualized recurring revenue): | $ 22,077,591 | $ 20,352,000 | $ 1,725,591 | 8.5 % | $ 22,077,591 | $ 20,352,000 | $ 1,725,591 | 8.5 % | ||
Transaction Customers: | ||||||||||
Corporate customers | 1,009 | 1,060 | (51) | -4.8 % | 995 | 1,062 | (67) | -6.3 % | ||
Academic customers | 337 | 320 | 17 | 5.3 % | 336 | 323 | 13 | 4.0 % | ||
Total customers | 1,346 | 1,380 | (34) | -2.5 % | 1,331 | 1,385 | (54) | -3.9 % | ||
Active Customer Accounts, Transactions and Annual Recurring Revenue
The Company defines active customer accounts as the sum of the total quantity of customers per month for each month in the period divided by the respective number of months in the period. The quantity of customers per month is defined as customers with at least one transaction during the month.
A transaction is an order for a unit of copyrighted content fulfilled or managed in the Platform.
The Company defines annual recurring revenue ("ARR") as the value of contracted Platform subscription recurring revenue normalized to a one-year period. For B2C ARR, this includes the annualized value of monthly subscriptions, meaning their monthly value multiplied by twelve.
Use of Non-GAAP Measure – Adjusted EBITDA
Research Solutions' management evaluates and makes operating decisions using various financial metrics. In addition to the Company's GAAP results, management also considers the non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP measure provides useful information about the Company's operating results.
The tables below provide a reconciliation of this non-GAAP financial measure with the most directly comparable GAAP financial measure. Adjusted EBITDA is defined as net income (loss), plus interest expense, other (income) expense, foreign currency transaction (gain) loss, provision for income taxes, depreciation and amortization, stock-based compensation, and other potential adjustments that may arise. Set forth below is a reconciliation of Adjusted EBITDA to net income (loss):
Quarter Ended March 31, | Nine Months Ended March 31, | |||||||||
2026 | 2025 | Change | % Change | 2026 | 2025 | Change | % Change | |||
Net Income (loss) | $ 860,205 | $ 216,469 | $ 643,736 | -297.4 % | $ 2,156,512 | $ (1,094,761) | $ 3,251,274 | 297.0 % | ||
Add (deduct): | ||||||||||
Other (income) expense | 162,607 | 327,042 | (164,435) | NM | 537,232 | 2,316,404 | (1,779,172) | -76.8 % | ||
Foreign currency translation loss (gain) | 12,529 | (44,519) | 57,048 | -128.1 % | 31,385 | (119,205) | 150,590 | 126.3 % | ||
Provision for income taxes | 22,168 | 13,410 | 8,758 | 65.3 % | 52,258 | 74,816 | (22,558) | -30.2 % | ||
Depreciation and amortization | 312,402 | 312,013 | 389 | 0.1 % | 944,893 | 930,341 | 14,552 | 1.6 % | ||
Stock-based compensation | 248,608 | 594,639 | (346,031) | -58.2 % | 674,539 | 1,546,950 | (872,411) | -56.4 % | ||
Adjusted EBITDA | $ 1,618,519 | $ 1,419,054 | $ 199,465 | 14.1 % | $ 4,396,819 | $ 3,654,545 | $ 742,275 | 20.3 % | ||
About Research Solutions
Research Solutions, Inc. (NASDAQ: RSSS) is a vertical SaaS and AI Company that simplifies research workflow for academic institutions, life science companies, and research organizations worldwide. As one of the only publisher-independent marketplaces for scientific, technical, and medical (STM) content, the Company uniquely combines AI-powered tools—including an intelligent research assistant and full-text search capabilities—with seamless access to both open access and paywalled research. The platform enables organizations to discover, access, manage and analyze scientific literature more efficiently, accelerating the pace of scientific discovery. For more information and details, please visit www.researchsolutions.com
Important Cautions Regarding Forward-Looking Statements
Certain statements in this press release may contain "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates," "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in the Company's most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Examples of forward-looking statements in this release include statements regarding enhanced product offerings, additional customers, creating long-term value for shareholders and the Company's prospects for growth. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements. For more information, please refer to the Company's filings with the Securities and Exchange Commission.
Research Solutions, Inc. and Subsidiaries | |||||||
March 31, | June 30, | ||||||
2026 | 2025 | ||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 12,050,396 | $ | 12,227,312 | |||
Accounts receivable, net of allowance of | 7,601,477 | 7,191,234 | |||||
Prepaid expenses and other current assets | 893,176 | 580,257 | |||||
Prepaid royalties | 132,426 | 925 | |||||
Total current assets | 20,677,475 | 19,999,728 | |||||
Non-current assets: | |||||||
Property and equipment, net of accumulated depreciation of | 57,859 | 60,769 | |||||
Intangible assets, net of accumulated amortization of | 8,836,604 | 9,686,241 | |||||
Goodwill | 16,372,979 | 16,372,979 | |||||
Deposits and other assets | 998 | 957 | |||||
Total assets | $ | 45,945,915 | $ | 46,120,674 | |||
Liabilities and Stockholders' Equity | |||||||
Current liabilities: | |||||||
Accounts payable and accrued expenses | $ | 6,687,477 | $ | 7,443,757 | |||
Deferred revenue, current portion | 11,105,272 | 10,702,120 | |||||
Contingent earnout liability, current portion | 7,310,763 | 7,363,152 | |||||
Total current liabilities | 25,103,512 | 25,509,029 | |||||
Non-current liabilities: | |||||||
Deferred revenue, long-term portion | 56,508 | — | |||||
Contingent earnout liability, long-term portion | 1,726,046 | 6,683,488 | |||||
Total liabilities | 26,886,066 | 32,192,517 | |||||
Commitments and contingencies | |||||||
Stockholders' equity: | |||||||
Preferred stock; | — | — | |||||
Common stock; | 33,154 | 32,480 | |||||
Additional paid-in capital | 42,023,679 | 39,059,557 | |||||
Accumulated deficit | (22,887,181) | (25,043,693) | |||||
Accumulated other comprehensive loss | (109,803) | (120,187) | |||||
Total stockholders' equity | 19,059,849 | 13,928,157 | |||||
Total liabilities and stockholders' equity | $ | 45,945,915 | $ | 46,120,674 | |||
| |||||||
Research Solutions, Inc. and Subsidiaries | |||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||
March 31, | March 31, | ||||||||||||
2026 | 2025 | 2026 | 2025 | ||||||||||
Revenue: | |||||||||||||
Platforms | $ | 5,160,565 | $ | 4,839,929 | $ | 15,506,250 | $ | 13,770,831 | |||||
Transactions | 6,960,996 | 7,821,434 | 20,720,147 | 22,849,233 | |||||||||
Total revenue | 12,121,561 | 12,661,363 | 36,226,397 | 36,620,064 | |||||||||
Cost of revenue: | |||||||||||||
Platforms | 703,669 | 610,306 | 1,936,705 | 1,777,315 | |||||||||
Transactions | 5,152,360 | 5,783,977 | 15,621,912 | 16,988,700 | |||||||||
Total cost of revenue | 5,856,029 | 6,394,283 | 17,558,617 | 18,766,015 | |||||||||
Gross profit | 6,265,532 | 6,267,080 | 18,667,780 | 17,854,049 | |||||||||
Operating expenses: | |||||||||||||
Selling, general and administrative | 4,908,149 | 5,398,145 | 14,976,885 | 15,627,248 | |||||||||
Depreciation and amortization | 312,402 | 312,013 | 944,893 | 930,341 | |||||||||
Total operating expenses | 5,220,551 | 5,710,158 | 15,921,778 | 16,557,589 | |||||||||
Income from operations | 1,044,981 | 556,922 | 2,746,002 | 1,296,460 | |||||||||
Other income | 83,919 | 78,868 | 305,897 | 496,392 | |||||||||
Accreted interest expense | (246,526) | — | (843,129) | — | |||||||||
Change in fair value of contingent earnout liability | — | (405,910) | — | (2,812,796) | |||||||||
Income (loss) before provision for income taxes | 882,374 | 229,880 | 2,208,770 | (1,019,944) | |||||||||
Provision for income taxes | (22,168) | (13,410) | (52,258) | (74,816) | |||||||||
Net income (loss) | 860,206 | 216,470 | 2,156,512 | (1,094,760) | |||||||||
Other comprehensive income (loss): | |||||||||||||
Foreign currency translation | 3,558 | (3,324) | 10,384 | (6,855) | |||||||||
Comprehensive income (loss) | $ | 863,764 | $ | 213,146 | $ | 2,166,896 | $ | (1,101,615) | |||||
Basic income (loss) per common share: | |||||||||||||
Net income (loss) per share | $ | 0.03 | $ | 0.01 | $ | 0.07 | $ | (0.04) | |||||
Weighted average common shares outstanding | 31,999,813 | 31,033,022 | 31,619,417 | 30,597,410 | |||||||||
Diluted income (loss) per common share: | |||||||||||||
Net income (loss) per share | $ | 0.03 | $ | 0.01 | $ | 0.07 | $ | (0.04) | |||||
Weighted average common shares outstanding | 32,435,370 | 32,139,935 | 32,154,594 | 30,597,410 | |||||||||
| |||||||||||||
Research Solutions, Inc. and Subsidiaries | |||||||
Nine Months Ended | |||||||
March 31, | |||||||
2026 | 2025 | ||||||
Cash flow from operating activities: | |||||||
Net income (loss) | $ | 2,156,512 | $ | (1,094,760) | |||
Adjustment to reconcile net income (loss) to net cash provided by operating activities: | |||||||
Depreciation and amortization | 944,893 | 930,341 | |||||
Stock options expense | 239,818 | 146,751 | |||||
Restricted common stock expense | 434,721 | 1,400,199 | |||||
Accreted interest expense | 843,129 | — | |||||
Adjustment to contingent earnout liability | — | 2,812,796 | |||||
Changes in operating assets and liabilities: | |||||||
Accounts receivable | (410,243) | (754,258) | |||||
Prepaid expenses and other current assets | (312,919) | 17,826 | |||||
Prepaid royalties | (131,501) | 311,938 | |||||
Accounts payable and accrued expenses | (724,921) | (338,502) | |||||
Deferred revenue | 459,660 | 1,331,920 | |||||
Net cash provided by operating activities | 3,499,149 | 4,764,251 | |||||
Cash flow from investing activities: | |||||||
Purchase of property and equipment | (28,609) | (11,571) | |||||
Net cash used in investing activities | (28,609) | (11,571) | |||||
Cash flow from financing activities: | |||||||
Proceeds from the exercise of stock options | 157,500 | — | |||||
Common stock repurchase | (47,385) | (908,393) | |||||
Payment of contingent acquisition consideration - Scite andFIZ | (3,766,263) | (91,174) | |||||
Net cash used in financing activities | (3,656,148) | (999,567) | |||||
Effect of exchange rate changes | 8,692 | (1,137) | |||||
Net increase (decrease) in cash and cash equivalents | (176,916) | 3,751,976 | |||||
Cash and cash equivalents, beginning of period | 12,227,312 | 6,100,031 | |||||
Cash and cash equivalents, end of period | $ | 12,050,396 | $ | 9,852,007 | |||
Supplemental disclosures of cash flow information: | |||||||
Cash paid for income taxes | $ | 52,258 | $ | 74,816 | |||
Non-cash investing and financing activities: | |||||||
Contingent consideration accrual on asset acquisition | $ | — | $ | 29,394 | |||
Common stock issued for Sciteearnout payment | $ | 2,180,142 | $ | — | |||
| |||||||
View original content to download multimedia:https://www.prnewswire.com/news-releases/research-solutions-reports-third-quarter-fiscal-year-2026-results-302772825.html
SOURCE Research Solutions, Inc.